This site is intended for health professionals only
This site is intended for health professionals only
1. World Health Organization 2003. Adherence to long-term therapies: evidence for action.
2. Partridge MR et al. Prim Care Resp J, 2011; 20: 315–23.
3. Hardwell A et al. Prim Care Resp J, 2011; 20: 92–6.
4.Qvar® Summary of Product Characteristics.
5. Leach CL et al. Chest, 2002; 122: 510–6.
6. Consensus guideline on the use of inhaler devices in asthma, Thomas et al 2009
7.Lenney J et al. Respir Med, 2000; 94: 496–500.
1. World Health Organization 2003. Adherence to long-term therapies: evidence for action.
2. Partridge MR et al. Prim Care Resp J, 2011; 20: 315–23.
3. Hardwell A et al. Prim Care Resp J, 2011; 20: 92–6.
4.Qvar® Summary of Product Characteristics.
5. Leach CL et al. Chest, 2002; 122: 510–6.
6. Consensus guideline on the use of inhaler devices in asthma, Thomas et al 2009
7.Lenney J et al. Respir Med, 2000; 94: 496–500.
8. Price DB et al. Int J Clin Pract, 1999; 53: 31–6.
IMPORTANT LINKS
MORE FROM COGORA
© Cogora 2024
Cogora Limited. 1 Giltspur Street, London
EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432
